On July 27, the brain-computer interface (BCI) sector within the A-share market exhibited robust performance overall. By the market's close, numerous stocks, including Aipon Medical, Intretech, Innovative Medical, and Hainan Haiyao, soared to their daily limit prices. According to data from Shuju Bao, the A-share market boasts a total of 25 stocks related to brain-computer interfaces. Since the beginning of the year, 14 of these stocks have been the focus of institutional research. Xiangyu Medical, Meihao Medical, and Aipon Medical have drawn the most attention, attracting research from 282, 191, and 189 institutions, respectively. Based on consensus forecasts from three or more institutions, the revenues of seven BCI concept stocks are anticipated to experience year-on-year growth in 2026. Meihao Medical, Shiji Huatong, and Intretech are projected to witness the most significant increases, with expected growth rates of 26.24%, 26.17%, and 23.8%, respectively.